Preliminary Program

8.00 - 8.30: Registration and coffee

8.30 - 8.35: Welcome

Leif Groop, Lund University

8.35 - 8.45: Opening Remarks

Olivier Arnaud, JDRF

8.45 - 9.45: Session 1: Major breakthrough in diabetes! What is needed? Views from industry and academia

Chair: Leif Groop, Lund University

2 x 30 min presentations.

- The view from academia. Academia addresses pharma's wish list and gives its view on what is needed for key advances in diabetes. (Stefano Del Prato, University of Pisa)

- The view from big pharma: Big pharma's great challenges in diabetes research. What we would like from academia in terms of research areas, collaborative efforts etc. (Allan Karlsen, Novo Nordisk)

9.45 – 10.15: Coffee break

10.15 – 11.45: Panel discussion

Can we identify some bottlenecks/gaps that prevent a major breakthrough in diabetes?

Panel members: Henning Beck-Nielsen, University of Southern Denmark; Marc Donath, University Hospital of Basel; Philip Just-Larsen, Sanofi; Allan Karlsen, Novo
Nordisk.

11.45 – 13.15: Lunch and networking

13.15 - 14.15: Session 2: Translation in diabetes: Can we strengthen collaborations?

Chair: Patrick Tricoli, Sanofi

3 x 20 min presentations.

- Open Innovation at Sanofi. (Ulrich Wendt, Sanofi)

- Open Innovation initiative in US. (Stephen Friend, Sage Bionetworks)

- How can biobanks contribute? (Tim Sprosen, University of Oxford)

14.15 - 14.45: Coffee break

14.45 - 15.45: Session 3: What has to happen now? The way forward?

Chair: Sylvie Bove, Lund University

3 x 20 min presentations.

- Bridging the gap in Germany: Spinnovator and other novel tools to expedite value creation in healthcare (Christian Stein, Ascenion)

- Strategies for capturing regional, national, European and international funding programs for diabetes research (Horst Domdey, BioM Biotech Cluster Development GmbH)

- New financial instruments for technology transfer (Johan Le Men, Inserm Transfert)

15.45 – 17.15: Panel discussion

What are the next steps? Can we propose initiatives with potential to bridge the gaps?

Panel members: Stephen Friend, Sage Bionetworks;Leif Groop, Lund University; Sven Rohmann, Burrill & Co; Christian Stein, Ascenion; Matthias Tschöp, Helmholtz Zentrum Munich/Teknische Universität Munich.

17.15 – 17.30: Concluding remarks